Oral intake of curcumin markedly activated CYP 3A4: in vivo and ex-vivo studies. - Wikidata - wikimedia - TriplyDB

Oral intake of curcumin markedly activated CYP 3A4: in vivo and ex-vivo studies.

Oral intake of curcumin markedly activated CYP 3A4: in vivo and ex-vivo studies.

http://www.wikidata.org/entity/Q37734897

about

Modulation of Metabolic Detoxification Pathways Using Foods and Food-Derived Components: A Scientific Review with Clinical Application Curcumin as therapeutics for the treatment of head and neck squamous cell carcinoma by activating SIRT1 Modulation of Hepatic Cytochrome P450 Enzymes by Curcumin and its Pharmacokinetic Consequences in Sprague-dawley Rats Curcumin Prevents Aflatoxin B₁ Hepatoxicity by Inhibition of Cytochrome P450 Isozymes in Chick Liver.Influence of curcumin on the pharmacodynamics and pharmacokinetics of gliclazide in animal models Aloe activated P-glycoprotein and CYP 3A: a study on the serum kinetics of aloe and its interaction with cyclosporine in rats.

P2860

Q35806779-ECAD8AB1-298E-4BE7-95A1-A6D9F31E9849 Q35989409-09B898E4-0EAE-4171-8B9C-0A3A2A8FC511 Q36675712-F54EC7AC-2797-4840-8958-EBC19006201A Q37450415-A9317833-F196-405D-AC15-6ECC33AD0D45 Q42049725-FD74766C-7C9D-4119-9625-773F416AC30B Q53613753-E4AD00B3-E23C-42CC-8DAD-CF23C812ADF4

P2860

Oral intake of curcumin markedly activated CYP 3A4: in vivo and ex-vivo studies.

http://www.wikidata.org/entity/Q37734897

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 10 October 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Oral intake of curcumin markedly activated CYP 3A4: in vivo and ex-vivo studies.

@en

Oral intake of curcumin markedly activated CYP 3A4: in vivo and ex-vivo studies.

@nl

type

label

Oral intake of curcumin markedly activated CYP 3A4: in vivo and ex-vivo studies.

@en

Oral intake of curcumin markedly activated CYP 3A4: in vivo and ex-vivo studies.

@nl

prefLabel

Oral intake of curcumin markedly activated CYP 3A4: in vivo and ex-vivo studies.

@en

Oral intake of curcumin markedly activated CYP 3A4: in vivo and ex-vivo studies.

@nl

P1433

Q37734897-AD52F464-49FF-4038-A939-09810A3D9E2B

P1476

Q37734897-4F782425-172B-4A1F-9C23-CEB1FDAEB233

P2093

Q37734897-04F8DD3C-6A2A-4022-9D8F-8FE0C84A025D

Q37734897-29A8CC15-EC98-42E4-979A-28BF49F80AA1

Q37734897-B6753159-DD83-4283-97DC-C2D4C81730F5

Q37734897-CEEFCEC0-AA51-4CE6-80D5-5688976CB63B

Q37734897-E7752F0C-BA62-471E-A252-6C6A7B82B029

P2860

Q37734897-0AFF572D-387D-41F9-9086-9CB45138A4AC

Q37734897-0ED68520-5CED-450A-A9D2-91A05FCFF63E

Q37734897-1A71E229-CAF6-4C7C-A24A-3916A00AB2F8

Q37734897-1D382658-7507-46A5-B110-119FEFB47A51

Q37734897-46192B01-FCC0-4DC1-B3C4-E5F973EA1FE4

Q37734897-49E0B364-BD5E-4AA5-99FD-27C93363422F

Q37734897-56B8606F-24E1-4BCC-B10B-C72510DBE123

Q37734897-5C1C78B3-713E-4356-BED0-E8D7530447FD

Q37734897-715B3F44-37FA-4988-A1DD-1BB26D33A89A

Q37734897-72124F1E-EDFE-405F-B302-D4129F10C8FA

P2888

Q37734897-1353D2D4-BD46-4BFC-B495-619BCE3C9BCF

P304

Q37734897-74214C14-CFEC-4DA3-B519-C1652D76B495

P31

Q37734897-CFB35BE9-3D0E-4A40-BFE5-0E3288B247F7

P356

Q37734897-B1909CDE-0278-4892-A889-744A12459DE0

P407

Q37734897-02822E04-E76A-495C-92CF-6EED521AF4C4

P478

Q37734897-EB067FD2-5625-4737-8E45-98ED3A83CC73

P50

Q37734897-1B859C39-4775-4952-BFDA-1B1576EA9980

Q37734897-6A701F19-AD94-4F80-8869-28211A169A0F

P577

Q37734897-08DF3ABC-7091-40CD-8CE0-0D83D6A2D5F0

P5875

Q37734897-D051C463-DD3B-43C9-B4E9-3FD85776C3BF

P698

Q37734897-837D2774-7A19-4CAB-822E-CA7F20D6D07D

P921

Q37734897-f3fa1ef4-ad57-485b-a645-9df34a90e345

P932

Q37734897-9AF8B983-5EF1-4F34-8192-0E9F50F57E0E

P356

P1433

Scientific Reports

P1476

Oral intake of curcumin markedly activated CYP 3A4: in vivo and ex-vivo studies.

@en

P2093

Ching-Ya Huang

http://www.w3.org/2001/XMLSchema#string

Pei-Dawn Lee Chao

http://www.w3.org/2001/XMLSchema#string

Shih-Ying Yang

http://www.w3.org/2001/XMLSchema#string

Yow-Wen Hsieh

http://www.w3.org/2001/XMLSchema#string

Yu-Hsuan Peng

http://www.w3.org/2001/XMLSchema#string

P2860

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

Systemic and nonrenal adverse effects occurring in renal transplant patients treated with mTOR inhibitors

Everolimus and sirolimus in combination with cyclosporine have different effects on renal metabolism in the rat

Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer

Clinical pharmacokinetics of everolimus.

A rapid and simple HPLC method for the determination of curcumin in rat plasma: assay development, validation and application to a pharmacokinetic study of curcumin liposome.

Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects

Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model.

Comparison of Anti-inflammatory Activities of Six Curcuma Rhizomes: A Possible Curcuminoid-independent Pathway Mediated by Curcuma phaeocaulis Extract.

P2888

P304

6587

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP06587

http://www.w3.org/2001/XMLSchema#string

P407

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-10-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266744287

http://www.w3.org/2001/XMLSchema#string

P698

25300360

http://www.w3.org/2001/XMLSchema#string

P921

P932

5377466

http://www.w3.org/2001/XMLSchema#string